Answers are grounded in this paper and cite their sources.
The U.S. Office of Human Research Protection (OHRP) has just issued draft guidance on the elements of informed consent it will require when research is conducted to evaluate treatment options within the current standard of care. The draft guidance (available at www.hhs.gov/ohrp/newsroom/rfc/comstdofcare.html) is open for public comment until December 23, 2014.OHRP regulations should provide a practical, fair approach to research on treatments that study subjects might have received from their physicians in the course of normal practice. However, this draft guidance is written in complex and ambiguous legalistic language that makes it difficult to determine exactly what behavior will . . .
No takes yet. Share an insight, caveat, or question.
A 2014 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: